What Is CIRS? Mold Illness Explained

Last Updated: June 17, 2026

By: Brian Karr · Co-Founder & Chief Inspection Officer, We Inspect

CIRS — Chronic Inflammatory Response Syndrome — is a multi-system illness triggered by biotoxins from mold in water-damaged buildings, and the people who develop it cannot recover without first removing the environmental source driving their exposure. An estimated 24–25% of the population carries a genetic variation that prevents normal biotoxin clearance, creating a state of sustained immune activation that does not resolve on its own.¹ If you have been sick for months or years with symptoms no test seems to explain, understanding CIRS may be the missing context you have needed.

CIRS is not a mold allergy. It is not a reaction to visible mold on a wall or a sneeze from spores. It is a failure at the cellular level — a body being continuously exposed to biotoxins it cannot neutralize, driving inflammatory cascades across multiple organ systems at once. The condition was first described clinically by Dr. Ritchie Shoemaker, and research over the past two decades has established it as a distinct, diagnosable, and treatable illness.²

This article covers what CIRS is, who gets it, what the symptom profile looks like, why standard medical workups miss it, and what the research shows about recovery. For even more information we have our complete guide to mold illness signs and CIRS symptoms.

CIRS Is Not a Mold Allergy — and That Distinction Matters

A mold allergy is an IgE-mediated immune response to mold spores. Your immune system recognizes spores as foreign, produces antibodies, and you develop a runny nose, watery eyes, or asthma symptoms when exposed. Remove the exposure and the response settles. That is an allergy — and that is not CIRS.

In CIRS, the problem is not overreaction to spores. It is a failure to clear biotoxins. Susceptible individuals inhale toxic compounds produced by mold — mycotoxins, hemolysins, inflammagens — and their immune system cannot tag them for elimination. The biotoxins circulate. They activate inflammatory signaling. And because the clearance mechanism is genetically impaired, the response keeps running. The immune system is not stuck in an allergic reaction — it is stuck in a biotoxin accumulation loop it cannot exit on its own.

I hear a version of the same story on almost every CIRS consultation call. A woman in Denver reached out last October after three years of unexplained fatigue, brain fog, and recurring sinus infections. Seven specialists, four different diagnoses, no treatment had moved the needle. She described it as feeling “like somebody poisoned me, and I just can’t figure out where the poison is coming from.” Her house had flooded four years earlier. Nobody had connected the two.

A 2024 systematic review in Annals of Medicine and Surgery called CIRS a “silent epidemic” — a condition affecting up to 25% of the population that most clinicians are not trained to recognize, and which is routinely misdiagnosed as fibromyalgia, ME/CFS, and anxiety.¹

The table below summarizes how CIRS and mold allergy differ across key clinical dimensions:

Who Gets CIRS? The Genetic Susceptibility Factor

Two people can live in the same mold-contaminated house for two years. One develops debilitating multi-system illness. The other feels fine. This is the point of confusion — and frustration — that CIRS patients describe most often. Their partner is not pretending to feel well. And the CIRS patient is not imagining their symptoms.

The explanation is genetic. Approximately 24–25% of the population carries HLA-DR gene variations that impair the body’s ability to recognize and tag mold biotoxins for immune clearance.² In these individuals, biotoxins are not flagged as foreign invaders. There is no antibody response. The toxins accumulate with each additional exposure, compounding the total biotoxin burden over months and years.

A 2024 case series in Mycotoxin Research documented this directly — the same mycotoxin exposure produced dramatically different clinical outcomes depending on a patient’s HLA haplotype, confirming that genetic susceptibility drives the wide variation in illness severity between people in identical exposure environments.³

This is also why CIRS can worsen over time in the same home, while a non-susceptible household member stays healthy. Every month of ongoing exposure adds to the accumulated biotoxin load in the susceptible individual. The immune activation deepens. Symptoms that began as mild fatigue or occasional brain fog escalate into something far harder to treat — which is why finding the source early matters so much.

What Does CIRS Feel Like? The Symptom Profile

The published clinical framework for CIRS identifies 37 symptoms across 13 body systems — from fatigue and brain fog to joint pain, numbness, unusual thirst, and light sensitivity. The breadth is part of why the condition gets misdiagnosed. No single organ system is failing. Everything seems slightly wrong, simultaneously.

The pattern people describe most often: exhaustion that does not improve with sleep, cognitive difficulty that one caller described as “thinking through wet cement,” and a sense of steady deterioration. Another caller — a 43-year-old former runner from Austin — told me he had reduced his training from five days a week to one. Not because he lacked motivation. Recovery from any exertion had stretched from hours into days.

A 2016 RNA-Seq study in Medical Research Archives confirmed that CIRS creates a measurable genomic signature — genome-wide shifts in innate immune function and metabolic pathways that distinguish CIRS patients from healthy controls.⁴ The study identified molecular hypometabolism — measurable suppression of cellular energy production — as a hallmark of untreated CIRS. That suppressed energy production is what the exhaustion actually is.

Other commonly reported symptom clusters include:

• Cognitive: memory loss, word-finding problems, difficulty concentrating, slowed processing
• Neurological: headaches, tingling or numbness, light sensitivity, static sensitivity, ice-pick pain
• Respiratory: shortness of breath with exertion, chronic cough, recurring sinus congestion
• Systemic: profound fatigue, muscle weakness, joint aches, morning stiffness, temperature dysregulation
• Unusual: excessive thirst, increased urination, appetite swings, abdominal pain

The simultaneous involvement of multiple systems is not coincidental. The inflammatory mediators central to CIRS — C4a, TGF-β1, MMP-9 — circulate systemically and disrupt cellular function at many sites at once. No amount of treating individual systems resolves the underlying driver.

Why Do All My Tests Come Back Normal?

This is the question almost every CIRS patient has asked before finding an accurate diagnosis. Standard blood panels — CBC, comprehensive metabolic panel, thyroid function, basic inflammation markers — are not designed to detect what CIRS disrupts. Your standard labs can be entirely normal while CIRS biomarkers are dramatically abnormal.

Accurate CIRS assessment requires specific biomarker testing: complement C4a, TGF-β1, MMP-9, VIP (vasoactive intestinal peptide), MSH (melanocyte-stimulating hormone), VEGF, and visual contrast sensitivity. These are not ordered in standard clinical workups. A physician who is not specifically familiar with CIRS will not think to check them.

The 2024 review by Dooley and colleagues in Annals of Medicine and Surgery confirmed that CIRS is routinely misdiagnosed as ME/CFS and fibromyalgia precisely because the distinguishing biomarkers are absent from standard care pathways.¹ Of 13 clinical studies reviewed, all 11 that evaluated treatment outcomes identified the Shoemaker Protocol as the only framework with documented efficacy for normalizing these specific markers.

The second reason standard workups miss CIRS: they never ask about the home. The patient is treated as a medical problem in isolation, without investigating whether continued environmental exposure is sustaining the immune state that no treatment can overcome. Until the source is identified, the most accurate biomarker panel in the world only documents an ongoing problem — it does not resolve it. Here’s why finding the source has to come first.

Is CIRS Reversible?

The research on recovery is consistently encouraging when the environmental source is identified and removed — that single step is where the recovery pathway begins. Not the binders. Not the protocol. Not the supplements. Those matter downstream, but none of them work while ongoing exposure continues to reload the biotoxin burden.

A 2013 review in The Scientific World Journal reported that 27 of 28 mold-illness patients returned to work after treatment that included source removal as the foundational first step.⁵ That is a 96% return-to-function rate in a population that had often been disabled by illness for years. What is notable is not just the outcome — it is the sequence. Source removal came first.

The trajectory without intervention is different. A longitudinal study in Frontiers in Immunology followed a nine-member family and an 80-person school building cohort with documented mold exposure over time. The natural course progressed: initial mucosal symptoms advanced to asthma, then to multi-system immune dysfunction, and ultimately to autoimmune conditions at rates substantially elevated above population norms.⁶ Early identification shortened — and in many cases prevented — that progression entirely.

One caller from New Jersey put the logic plainly: “Until we’re out of the mold, I don’t want to waste testing for health on that kind of thing until we know we’re out of the mold, we know our pathways can be cleansed, and we know we can start to heal.” She was right. The home has to be addressed first. Everything else is sequence-dependent.

Key Takeaways

• CIRS is a multi-system illness caused by biotoxin accumulation from mold in water-damaged buildings — not a mold allergy, not a psychological condition, and not something that resolves on its own without source removal. This is why understanding the root cause is so important.
• Approximately 24–25% of the population carries HLA-DR gene variations that prevent normal biotoxin clearance, explaining why one household member can be severely ill while another in the same home feels fine.
• Standard medical lab work does not include CIRS biomarkers. Normal test results do not rule out CIRS.
• Symptoms span 13 organ systems — including profound fatigue, cognitive impairment, neurological changes, and respiratory symptoms — which is why CIRS is routinely misdiagnosed as fibromyalgia or ME/CFS.
• Recovery is well-documented when the environmental source is found and removed. Finding the source is the first step — and it requires knowing where to look in the building.

What This Means for Your Health

CIRS is not rare. It is not fringe medicine. It is a genomically confirmed condition affecting roughly one in four people exposed to water-damaged buildings — and the most important variable in the entire illness trajectory is whether the environmental source ever gets found.

Symptoms can improve. People do recover. The patients I speak with who have the most significant turnarounds are consistently the ones who stopped treating symptoms in isolation and started asking what their building was doing to their body. Source-level exposure mapping is the tool built specifically for that question — designed to find hidden mold contamination at the sites where it is actively growing, not just measure what has settled in the air.

If you recognize this pattern in your own health history, the starting point is not another specialist. It is finding out what your home environment is actually contributing to your exposure load.

Next Steps

If you want to know what your home is actually doing to your body, we can find out. We Inspect uncovers hidden mold contamination, ranks what truly drives your exposure, and delivers a contractor-ready Remediation Recovery Blueprint designed to meaningfully reduce exposure so your body can heal — without wasting tens of thousands on unnecessary fixes that won’t move the needle. Get My Free Exposure Consultation

Frequently Asked Questions

What is CIRS and what causes it?

CIRS (Chronic Inflammatory Response Syndrome) is a multi-system illness caused by chronic exposure to biotoxins from mold in water-damaged buildings. People with specific HLA-DR gene variants cannot clear these biotoxins normally, allowing them to accumulate and drive a self-amplifying inflammatory response across multiple organ systems that does not resolve without removing the exposure source.

How is CIRS different from a mold allergy?

A mold allergy is an IgE-mediated immune response to spores that typically resolves when exposure ends. CIRS is a biotoxin accumulation condition driven by a genetic impairment in toxin clearance. Standard allergy testing is negative in CIRS, the diagnostic biomarkers are completely different, and the treatment approach — centered on source removal — is entirely distinct. For more, check out our blog CIRS vs. mold allergy.

Who is at risk of developing CIRS?

Anyone with HLA-DR genetic susceptibility variants — approximately 24–25% of the population — is at elevated risk of developing CIRS when exposed to a water-damaged building. Risk increases with duration of exposure and total biotoxin load. People who have experienced prior mold exposure may have a compounded burden that lowers the threshold for illness with subsequent exposures.

Can CIRS be diagnosed with standard blood work?

No. Standard CBC and metabolic panels do not include CIRS biomarkers. Accurate assessment requires specific testing for C4a, TGF-β1, MMP-9, MSH, VIP, and VEGF. These markers are abnormal in active CIRS while routine panels appear normal — which is the primary reason CIRS is so frequently missed or misdiagnosed as fibromyalgia or ME/CFS.

Is CIRS permanent?

CIRS is not inherently permanent. Clinical research documents robust recovery rates when the biotoxin source is identified, removed, and treatment is initiated in the correct sequence. The critical barrier to recovery is ongoing re-exposure. Continued exposure makes recovery impossible regardless of treatment. Identifying and eliminating the environmental source is the non-negotiable foundation of any successful CIRS recovery.

Why do I feel worse at home and better when I travel?

Location-specific symptom patterns are among the clearest indicators of an environmental exposure source. When symptoms consistently improve away from home and worsen upon return, the building itself is driving ongoing biotoxin exposure. This pattern should prompt a source-level inspection of the home — not more medical testing — because the environment is the variable that changes, not your body chemistry.

What is the first step in treating CIRS?

The first step is identifying and removing the environmental source of biotoxin exposure. This must precede any treatment protocol. Binders, VIP nasal spray, and the other steps in the Shoemaker Protocol cannot produce durable recovery while ongoing exposure continues to reload the biotoxin burden. Source-level exposure mapping of the home provides the data needed to act on that first step.

References

1. Dooley M, Vukelic A, Jim L. Chronic inflammatory response syndrome: a review of the evidence of clinical efficacy of treatment. Annals of Medicine and Surgery. 2024. doi:10.1097/MS9.0000000000002718
2. Rao TR, Sravya G, Kaushik T, Akshaya D. Chronic Inflammatory Response Syndrome (CIRS): A Review of Diagnosis, Immunological Mechanisms and Treatment Challenges. International Journal of Creative and Systematic Research and Reviews. 2025;8(7). doi:10.47191/ijcsrr/v8-i7-09
3. Saghir S, Ansari RA. HLA gene variations and mycotoxin toxicity: Four case reports. Mycotoxin Research. 2024;40:57–68. doi:10.1007/s12550-023-00517-y
4. Shoemaker RC. RNA-Seq on patients with chronic inflammatory response syndrome (CIRS) treated with vasoactive intestinal peptide (VIP) shows a shift in metabolic state and innate immune functions that coincide with healing. Medical Research Archives. 2016;4(7). doi:10.18103/MRA.V4I7.862
5. Hope J. A Review of the Mechanism of Injury and Treatment Approaches for Illness Resulting from Exposure to Water-Damaged Buildings, Mold, and Mycotoxins. The Scientific World Journal. 2013;767482. doi:10.1155/2013/767482
6. Rinne K, Tuuminen T. Severe sequelae to mold-related illness as demonstrated in two Finnish cohorts. Frontiers in Immunology. 2017;8:382. doi:10.3389/fimmu.2017.00382

This article is for informational purposes only and does not constitute professional medical advice. If you believe mold or other environmental hazards may be affecting your health, consult your healthcare provider.

complete guide to mold illness signs and CIRS symptoms